DOI: 10.1055/s-00034924

Nuklearmedizin - NuclearMedicine

LinksSchließen

Referenz

Lovrec P, Bradshaw T, Kyriakopoulos C. et al.
PSMA-based 18F-DCFPyL PET/MRI for Prediction of Progression and Assessment of Response to Neo-Adjuvant Chemohormonal Therapy in Men with High-Risk Primary Prostate Cancer.

J Nucl Med 2021;
2021 (62) 1356

Bibliographische Angaben herunterladen